What You Need to Know About Marijuana: The 2026 Comprehensive Guide

Marijuana is the most widely used plant-based psychoactive substance in the world. According to the World Health Organization, approximately 209 million people worldwide use it regularly (WHO, 2023). In Poland, the conversation about marijuana is entering a new phase, in which the medical and recreational contexts are becoming increasingly distinct.

Since 2017, patients in Poland have been legally able to use medicinal marijuana with a prescription. Standardized dried hemp products with varying THC and CBD ratios are available. According to patient.gov.pl, the number of Rpw prescriptions issued annually exceeded 300,000 in 2024. At the same time, the market for CBD products from hemp, with THC content not exceeding 0.31 TP3T, is thriving.

This guide explores cannabis from a scientific, legal, and practical perspective. We explain what cannabinoids are, how the endocannabinoid system works, the most common methods of consumption, and when cannabis becomes a medicine. We draw on data from PubMed, WHO, EMCDDA, Lancet, and Polish Ministry of Health sources.

KEY INFORMATION
– Medicinal marijuana has been legal in Poland since 2017 and is available only on prescription. In 2024, over 300,000 such prescriptions were issued (patient.gov.pl, 2024).
– The consumer market is divided into CBD from hemp (THC below 0.3%, over-the-counter) and medicinal herb (THC 5-22%, prescription only).
– The plant contains over 100 cannabinoids. The most important are THC (psychoactive) and CBD (non-psychoactive) (PMC, Frontiers in Pharmacology, 2020).
– The human endocannabinoid system (ECS) was only discovered in the 1990s. It regulates sleep, appetite, pain, mood, and immunity.
– The risk of marijuana dependence is 9% in adults and 17% in adolescents (NIDA, 2020).

What is marijuana and where does it come from?

Marijuana is the dried inflorescences and leaves of the female hemp plant (Cannabis sativa L.), containing psychoactive cannabinoids, primarily THC. The plant originates from Central Asia and has been used by humans for at least 5,000 years. The oldest archaeological evidence of cannabis use comes from China (PubMed, 2019).

The cannabis plant is divided into three basic botanical varieties: sativa, indica, and ruderalis. In therapeutic and recreational contexts, the differences between them lie in their cannabinoid and terpene profiles. Sativa is associated with stimulating and creative effects, while indica with relaxation and sedation. Modern strains, however, are primarily hybrids of both lineages.

Historical uses of marijuana include traditional medicine in China, India (where it holds sacred status in Ayurveda), ancient Greece, and Egypt. In 19th-century Europe and the United States, cannabis was a standard pharmacopoeial treatment for pain, insomnia, and seizures. Prohibition was introduced in the 20th century under the pressure of prohibitionist policies.

Today, the distinction between "hemp" (low in THC) and "marijuana" (higher in THC) is legal, not botanical. Both are derived from the same plant, Cannabis sativa L. The difference lies solely in the cannabinoid profile bred by humans through decades of genetic selection.

Cannabis botany and genetics

Cannabis sativa L. is an annual dioecious plant. This means that male and female plants are separate, and only the female plants produce flowers rich in cannabinoids. Trichomes, tiny resin glands on the surface of flowers and leaves, are the site of synthesis of THC, CBD, and over 500 other chemical compounds (Nature, 2021).

Genetic selection since the 1960s has led to a significant increase in the THC content of recreational marijuana. The average THC content in samples seized by the DEA increased from approximately 11 TP3T in 1970 to 15-221 TP3T in 2020. (PubMed, 2021). This has significant health and legal consequences.

Differences between hemp and marijuana

Hemp (fiber hemp) is a plant with a THC content below 0.31 TP3T, in accordance with EU and most international law. Traditionally cultivated for its fiber, seeds, and oil, it is now also used as a source of CBD. It does not produce psychoactive effects and is not controlled as a narcotic substance under Polish law.

Marijuana is hemp with a THC content above 0.31 TP3T, typically 5-251 TP3T. In medical settings, production takes place under sterile conditions, in accordance with GMP standards. The dried herb has standardized concentrations, which are listed on the packaging. This is a key difference from the illegal market, where consumers don't know the exact cannabinoid content.

Citation capsule: In Poland, recreational marijuana remains illegal, while hemp with a THC content below 0.3% is permitted for sale (Journal of Laws 2005 No. 179 item 1485). Medicinal marijuana requires a prescription from the Rpw since 2017 and is dispensed in pharmacies with the appropriate permit.

What cannabinoids does marijuana contain?

Marijuana contains over 100 different cannabinoids, about 200 terpenes, and 20 flavonoids. The two most important cannabinoids are THC (tetrahydrocannabinol) and CBD (cannabidiol). In typical medicinal marijuana, the THC content is 5-221 TP3T, and CBD 0.5-151 TP3T (PMC, Frontiers in Pharmacology, 2020). Other cannabinoids are usually present in trace amounts.

THC is the only highly psychoactive cannabinoid. It's responsible for the "high," altered perception of time, appetite stimulation, and euphoria. CBD doesn't induce psychoactivity and often modifies the effects of THC, reducing anxiety and paranoid symptoms. This explains why the THC:CBD ratio is crucial in medical marijuana.

The remaining cannabinoids, known as minority cannabinoids, include CBG (cannabigerol), CBN (cannabinol), CBC (cannabichromene), and THCV (tetrahydrocannabivarin). Each has a unique profile of action. CBN is mildly sedative and is formed from the oxidation of THC. CBG is a precursor to the other cannabinoids and activates different receptors than CBD.

THC – how does the psychoactive ingredient work?

THC binds to the CB1 receptor, found primarily in the central nervous system. CB1 is most concentrated in the hippocampus (memory), cerebellum (coordination), cerebral cortex (perception), and striatum (motivation). Activation of CB1 by THC explains the wide range of psychoactive effects (PMC, Journal of Neuroscience, 2012).

Doses below 5 mg of THC usually produce mild effects: relaxation, increased appetite, and altered perception. Doses of 5-10 mg produce a classic "high" with euphoria and impaired concentration. Doses above 20 mg, especially in new users, can cause anxiety, paranoia, and psychotic symptoms (Lancet of Psychiatry, 2019).

CBD – a non-psychoactive modulator

CBD does not produce psychoactive effects because it binds weakly and indirectly to CB1 and CB2 receptors. It works primarily by modulating anandamide, activating the 5-HT1A (serotonin) receptor, and influencing TRPV1 ion channels. It has documented anxiolytic, anti-inflammatory, and anticonvulsant effects (WHO, 2018).

In 2018, the FDA approved Epidiolex, a pure CBD drug, for the treatment of resistant forms of childhood epilepsy (Dravet syndrome and Lennox-Gastaut syndrome). It is the first non-psychoactive cannabinoid ever to receive drug designation. The result: a 36-44% reduction in seizures in children (New England Journal of Medicine, 2018).

Terpenes and the Entourage Effect

Terpenes are aromatic organic compounds responsible for the scent of marijuana. The most important are myrcene (earthy, sedative), limonene (citrusy, mood-boosting), linalool (lavender, calming), beta-caryophyllene (peppery, anti-inflammatory), and pinene (piney, concentration-enhancing). They work synergistically with cannabinoids.

The entourage effect is a phenomenon in which the full profile of cannabinoids and terpenes produces a stronger and more subtle effect than individual compounds (PMC, British Journal of Pharmacology, 2011). Therefore, medicinal herbs usually have a broader effect than THC alone or CBD in isolate form.

Unique observation: The difference between medical and recreational marijuana isn't just about legality. It's about controlling the dosage. Pharmacy herb is labeled with the exact THC and CBD content, origin, batch number, and laboratory analysis date. It's like the difference between a standardized drug and herb from the market. The same molecule, but different predictability of effect.

How does the human endocannabinoid system work?

The endocannabinoid system (ECS) is a cell signaling system discovered only in the 1990s during THC research. It regulates sleep, appetite, mood, pain, memory, reproduction, and immunity. It consists of receptors (CB1 and CB2), endogenous ligands (anandamide and 2-AG), and metabolic enzymes (FAAH and MAGL) (PMC, Cold Spring Harbor Perspectives, 2019).

CB1 receptors are found primarily in the central nervous system, with the highest concentrations in the hippocampus, cerebellum, and basal ganglia. CB2 receptors are located primarily in immune cells, the spleen, the tonsils, and to a lesser extent in the peripheral nervous system. This asymmetric distribution explains the diverse effects of cannabinoids.

Anandamide and 2-AG are endogenous cannabinoids produced by our bodies in response to various stimuli. They act as "silencers" of neural signals. When a neuron sends an excessively strong signal, endocannabinoids act via retrograde signaling, reducing the intensity of the transmission. This is crucial for regulating homeostasis.

ECS and chronic pain

CB1 receptors in the spinal cord and brain modulate pain perception. Activation of CB1 by THC reduces the transmission of pain signals at the spinal level. In a 2015 meta-analysis of 28 clinical trials, THC demonstrated efficacy comparable to codeine in treating chronic pain (CAVITY, 2015). 37% patients experienced relief.

CBD acts on pain primarily through TRPV1 (capsaicin) receptors and by inhibiting the COX-2 enzyme (inflammation). The different mechanisms of THC and CBD explain why the combination of both is more effective than either alone. This is the basis for rational formulation of medical marijuana.

ECS and mental health

The CB1 receptor modulates the release of mood-related neurotransmitters: dopamine, serotonin, GABA, and glutamate. Disturbances in the ECS are observed in depression, generalized anxiety disorder, PTSD, and schizophrenia (PMC, 2019).

The paradox: THC in low doses reduces anxiety, but in high doses it increases it. This is a classic "biphasic" profile. A dose of 2.5-5 mg of THC has an anxiolytic effect, while 15-20 mg can induce panic. CBD does not exhibit this profile and consistently reduces anxiety across a wide range of doses, from 25-600 mg.

ECS and appetite

THC stimulates appetite by activating CB1 in the hypothalamus, which regulates hunger. This familiar "munchies" phenomenon has practical medical applications in cancer patients with cachexia and in HIV/AIDS patients. Dronabinol (synthetic THC) has been an officially registered treatment for appetite loss in the US since the 1980s.

Citation capsule: The endocannabinoid system regulates key physiological processes through CB1 (CNS) and CB2 (immune system) receptors. Discovered in the 1990s during THC research, it is now one of the fastest-growing areas of neuropharmacology (PMC, Cold Spring Harbor Perspectives, 2019).

What are the methods of consuming marijuana?

Marijuana consumption methods vary in bioavailability, speed of action, and duration of effect. The most popular are inhalation (smoking), vaporization, sublingual oils, and edibles. Each method has a different pharmacokinetic profile. Vaporization of dried herb has the highest THC bioavailability, 30-35%, compared to 6-20% for oral forms (Frontiers in Pharmacology, 2020).

The choice of method of administration depends on the therapeutic goal. Rapid effects (pain attacks, chemotherapy nausea) require inhalation or vaporization. Long-term effects (chronic nocturnal pain, insomnia) are better achieved through edibles or oils. Medical marijuana often combines several forms to cover the entire 24-hour period.

Inhalation, or classic smoking

Smoking a joint or pipe is the oldest method of consumption. The effect occurs in 2-10 minutes, peaks in 30 minutes, and lasts 2-4 hours. Bioavailability is 10-35% depending on the smoking technique. Disadvantage: combustion produces tar, benzopyrenes, and carcinogens, similar to smoking tobacco (WHO, 2016).

Smoking is not a recommended form of administration for medical marijuana. Doctors prescribing Rpw herb typically recommend a vaporizer, which provides a pure therapeutic effect without combustion products. Smoking remains a recreational activity and, as mentioned, illegal in Poland.

Vaporization of herbs

A vaporizer heats the herb to 180-210 degrees Celsius, releasing cannabinoids and terpenes as vapor without burning the plant matter. This is a much safer method than smoking. The effect occurs in 5-15 minutes, with a bioavailability of 30-351 TP3T, and a duration of 1-3 hours (PMC, 2020).

Vaporization is currently the standard method of administering medicinal cannabis in Europe. It allows for precise dosing through shorter inhalations and lower temperatures. Terpene profiles are preserved, enhancing the entourage effect. Medical devices (Volcano, Mighty) adhere to GMP standards.

Sublingual oils and tinctures

Cannabinoid oils (CBD, THC, or mixed) are administered sublingually, held under the tongue for 60-90 seconds for transmucosal absorption. The effect occurs within 15-45 minutes, with a bioavailability of 13-19%, and a duration of action of 4-8 hours. This is the most common form of CBD in Poland.

The advantages of oils include precise drop-by-drop dosing, long duration of action, and the absence of inhalation. The disadvantage is a slower onset of effect compared to vaporization. For medical marijuana, oils are available in pharmacies as foreign preparations, less often as ready-made Polish products.

Edibles

Gummies, cookies, chocolates, and drinks containing THC or CBD are edibles. They are absorbed through the gastrointestinal tract. The effect occurs within 60–180 minutes, but is significantly stronger and longer than inhalation: 6–12 hours. This is due to THC being metabolized in the liver into 11-hydroxy-THC, which is significantly more psychoactive.

The downside to edibles is the difficulty of dosing. The effect takes time to appear, so untrained individuals often "add" another dose, leading to an overdose. In the US (where it's legal), the most common hospital admissions are for edibles, not smoking (Annals of Internal Medicine, 2019).

From the Bucha editorial office: In conversations with patients with RPW prescriptions, questions about vaporizers most often arise. Few doctors explain precisely how to select the right temperature and inhalation volume. Our observations: for older people who have never inhaled, the entry threshold is significantly higher than for those already familiar with vaping. This is important when planning therapy.

Topical products

Ointments, balms, and creams containing cannabinoids act locally on the skin, muscles, and joints. They do not significantly enter the systemic circulation, so they do not produce psychoactive effects, even with THC. Applications: joint pain, muscle tension, and skin conditions (psoriasis, atopic dermatitis, acne).

What are the indications for medicinal marijuana?

Medicinal marijuana is used for specific clinical indications. The most common are chronic pain (approximately 45% prescriptions in Poland), spasticity in multiple sclerosis (MS), nausea and vomiting associated with chemotherapy, refractory epilepsy, and PTSD. Efficacy in these indications has been documented in systematic reviews (BMJ, 2021).

The Polish prescription procedure for RPW is based on physician assessment. There is no strict list of "approved indications," as in some countries. The decision to pursue therapy is individual and requires exhaustion of standard treatment methods. Medical marijuana is typically a second- or third-line therapy, not a first-line option.

Chronic and neuropathic pain

Neuropathic pain (nerve damage) is the most common indication for medical marijuana. A 2018 Cochrane meta-analysis included 16 studies with 1,750 patients. It showed moderate effectiveness of cannabinoids in reducing neuropathic pain by approximately 30% compared to placebo (Cochrane, 2018). The effect is comparable to gabapentin.

Chronic pain associated with oncological diseases, fibromyalgia, and endometriosis also finds support in research. Mechanism: THC acts on CB1 receptors in the spinal cord and brain, while CBD acts through TRPV1 and COX-2. This synergistic effect is crucial, which is why medicinal herbs usually contain a balance of THC and CBD.

Multiple sclerosis and spasticity

MS is an autoimmune disease of the central nervous system. Spasticity, or excessive muscle tension, occurs in 80% patients in advanced stages. Sativex (nabiximols), a drug based on a 1:1 THC:CBD marijuana extract, has been approved in the EU for the treatment of spasticity in MS since 2010. (EMA, 2010).

Studies show that 40-50% MS patients experience significant relief from spasticity after using Sativex or medicinal herbs. Other benefits include improved sleep quality and reduced pain. Sativex is not funded by the National Health Fund in Poland; patients cover the cost themselves.

Oncology, nausea and cachexia

Dronabinol and nabilone (synthetic THC) have been registered as antiemetic drugs in chemotherapy in the US since the 1980s. In Poland, the medicinal herb Rpw is used in oncology patients for persistent nausea, loss of appetite, and pain. The antiemetic efficacy of THC surpasses that of metoclopramide in classical cytotoxic regimens.

Cachexia (wasting) is a life-threatening condition in patients with advanced cancer. THC stimulates appetite by activating CB1 in the hypothalamus. Maintaining body weight improves prognosis. In a 2018 clinical trial, THC increased calorie intake by 23% in cancer patients (PubMed, 2018).

Treatment-resistant epilepsies

Epidiolex (pure CBD) is approved by the FDA and EMA for the treatment of three refractory epilepsy syndromes: Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. A 36-44% seizure reduction in children (New England Journal of Medicine, 2018). This is one of the most groundbreaking recordings.

In Poland, Epidiolex is available as an imported drug, usually for direct import. The cost of monthly therapy is 3,000-8,000 PLN, and is rarely reimbursed. For pediatric patients, it is often the only option after traditional antiepileptic drugs have been exhausted.

PTSD and anxiety disorders

Post-traumatic stress disorder (PTSD) has been an official indication for medical marijuana in many US states and several EU countries since 2021. Mechanism: Cannabinoids modulate emotional responses in the amygdala and hippocampus. In Poland, PTSD is less frequently indicated on prescriptions, but it does appear in clinical practice.

What is the legal status of marijuana in Poland in 2026?

Recreational marijuana remains illegal in Poland. Possession, cultivation, and trade are punishable under the Act of 29 July 2005 on Counteracting Drug Addiction (Journal of Laws 2005 No. 179 item 1485). Possession of up to 3 grams may result in derogation proceedings, but larger amounts result in criminal liability with a penalty of up to 3 years in prison.

Medicinal marijuana has been legal since November 1, 2017, following an amendment to the Act on Counteracting Drug Addiction. It is available only with a prescription (Rpw), i.e., a prescription for a narcotic drug with a pink copy. The Rpw prescription procedure requires a licensed physician, a specific diagnosis, and dispensing at a pharmacy licensed to trade in narcotics.

The hemp (CBD) market is fully legal in Poland, provided the THC content of the product does not exceed 0.31 TP3T. This includes CBD herb, CBD oils, cosmetics, hemp seed foods, and other products. The market is estimated at approximately €130 million annually in 2024, with a forecast growth of €200 million by 2028. (Hemp Facts, 2024).

How to get an Rpw prescription?

A prescription for medical marijuana is issued by a licensed physician, typically a neurologist, oncologist, anesthesiologist, psychiatrist, or internist with certifications in pain management. Not every physician issues a prescription, so patients often need to seek out a clinic that specializes in medical cannabis therapy.

The procedure includes a detailed medical interview, diagnosis verification, analysis of prior treatment, and a safety assessment (psychological controversies, pregnancy, age under 18). After positive qualification, the doctor issues a prescription (RPW) with the dosage, form (vaporized herb, oil), and quantity for 30 days. The prescription is valid for 30 days from issuance.

How much does medical marijuana therapy cost?

Medicinal marijuana in Poland is not reimbursed by the National Health Fund (NFZ). Patients cover the full cost. The price of medicinal marijuana is 35-65 PLN per gram, depending on the strain and THC/CBD concentration. Average monthly consumption of 30-60 g translates to a monthly cost of 1050-3900 PLN. This is one of the main barriers to access.

A visit to a doctor authorized to issue Rpw typically costs 250-500 PLN. Subsequent follow-up visits every 3-6 months cost 150-300 PLN. Some clinics offer cheaper consultation packages. Additional costs include a vaporizer (500-2500 PLN), accessories (grinder, tissue paper, filters).

How to legally buy CBD without a prescription?

CBD hemp products are sold in specialty stores, pharmacies, and online. They don't require a prescription, as their THC content is below 0.31 TP3T. Legal categories include: CBD herbs, CBD oils, cosmetics, dietary supplements (after EFSA authorization), and herbal edibles.

Product quality should be confirmed by a certificate of analysis (COA) from an independent laboratory. Reputable brands publish a COA for each batch. They check for cannabinoid content, pesticides, heavy metals, and mycotoxins. The absence of a published COA is a red flag.

Citation capsule: Medicinal marijuana in Poland has been available since 2017 only on prescription, with the cost of therapy around PLN 1,050-3,900 per month without reimbursement from the National Health Fund (NFZ).patient.gov.pl, 2024). CBD products from hemp (THC below 0.3%) are legal without a prescription and represent a market worth €130 million per year.

What are the side effects and risks of marijuana?

Marijuana has a safety profile similar to many psychotropic medications, but it is not without risks. The most common side effects include dry mouth, drowsiness, dizziness, increased appetite, and tachycardia. According to a 2021 BMJ review, 30-40% of medical marijuana patients report mild side effects in the first weeks of therapy (BMJ, 2021). They disappear after acclimatization.

The risks primarily relate to THC, not CBD. CBD is considered very safe, with the WHO assessing no significant risk of abuse or psychoactive effects at doses up to 1500 mg per day (WHO, 2018). THC, on the other hand, can cause anxiety, paranoia, psychosis, and addiction, especially in sensitive individuals.

Marijuana addiction

Marijuana is addictive, although less so than nicotine or alcohol. The risk of addiction for regular users is 9% in the general population and 17% in those starting in their teens (NIDA, 2020). For comparison: nicotine 32%, alcohol 15%, cocaine 17%.

Marijuana withdrawal symptoms include irritability, insomnia, decreased appetite, anxiety, and depressed mood. They persist for 1-2 weeks after discontinuation. They are less severe than those seen with alcohol or opioids, but they are still real. This suggests cautious dosing, especially in sensitive individuals.

Risk of psychosis

A 2019 Lancet Psychiatry meta-analysis found that regular use of high-THC marijuana (above 10%) increases the risk of a psychotic episode three-fold compared to non-users (Lancet of Psychiatry, 2019). The risk is greatest in adolescents, whose brains are still developing, and in those with a family history of the condition.

CBD has the opposite effect, reducing the risk of psychosis. Therefore, medical marijuana with a THC:CBD balance is safer than recreational marijuana with THC alone. Balanced or CBD-dominant medical marijuana has the safest profile for people with mental health issues.

Drug interactions

Cannabinoids, including THC and CBD, inhibit cytochrome P450 enzymes (CYP3A4, CYP2C9, CYP2C19). This affects the metabolism of many drugs. Particular caution should be exercised with: warfarin, statins, antiepileptic drugs (clobazam, valproate), some antidepressants, immunosuppressants (PMC, 2019).

Before initiating medical marijuana therapy, it's essential to review your current medication. Your doctor should assess the risk of interactions. Sometimes a dose adjustment is sufficient, sometimes a break of 2-4 hours is sufficient, and sometimes it's necessary to discontinue marijuana in favor of another therapy.

Driving

Driving under the influence of THC is punishable in Poland as driving under the influence of alcohol. THC impairs coordination, reaction time, and distance perception. The detection threshold for THC in blood is 1 ng/ml. THC is detectable in urine 3-30 days after the last use (depending on frequency). This is important for professional drivers.

Patients undergoing Rpw therapy are not exempt from these regulations. Most doctors recommend not driving at all or for at least eight hours after their last dose of THC. CBD does not produce this effect and is not subject to driving restrictions.

Contraindications to medical marijuana

Absolute: pregnancy and breastfeeding, age under 18 years (with pediatric exceptions), active psychosis, unstable cardiovascular disease, allergy to cannabinoids. Relative: depression with suicidal thoughts, acute bipolar disorder, addiction to other substances, severe liver failure.

The decision regarding therapy always rests with the treating physician. Patients should provide detailed information about all medical conditions, medications, and substances used. Concealing medical information is a major cause of complications with cannabinoid therapy.

What is the difference between recreational and medicinal marijuana?

The difference between recreational and medicinal marijuana is multifaceted: legal, qualitative, safety, and intended use. Medicinal marijuana is a standardized pharmaceutical product, sourced from GMP cultivation, with declared THC and CBD concentrations. Recreational marijuana comes from uncontrolled sources and may be contaminated with pesticides, heavy metals, or synthetic cannabinoids. Recreational marijuana remains illegal in Poland.

The purpose of use is fundamentally different. Medicinal use is for treating a specific condition under medical supervision. Recreational use is for getting high without medical supervision. This difference in purpose influences the risk profile, use patterns, and long-term health consequences.

Quality control and standardization

Medicinal herbs (e.g., Bedrocan, Tilray, Aurora) are produced in accordance with GMP (Good Manufacturing Practice) standards. Each batch comes with a certificate of analysis: THC and CBD content (with a tolerance of +/- 5%), terpene profile, and tests for pesticides, heavy metals, mycotoxins, and microorganisms. The label includes all this information, plus the harvest date and expiration date.

The illegal market offers no quality control. Laboratory tests of seized marijuana in the US and EU show the presence of pesticides in 40-60% samples, heavy metals in 20%, mycotoxins in 15%, and synthetic cannabinoids (K2, Spice) added without the consumer's knowledge in 5-10% samples (EMCDDA, 2022).

Medical supervision vs. self-use

A patient with a prescription for RPW has regular doctor visits (usually every 3-6 months). The doctor monitors the effectiveness of the therapy, side effects, possible interactions, and the need for dosage adjustments. This is a crucial safety feature. Using marijuana alone does not offer this protection.

Medical dosing typically begins with the lowest dose ("start low, go slow"), e.g., 0.1 g of vaporized herb per day, and is gradually increased. Recreational dosing is erratic, with "habituation" to higher doses and an increasing risk of psychosis. The profile of the use pattern directly impacts health outcomes.

Bucha Market Watch Q1 2026: In our store, we're noticing a clear trend among customers over 50. They're increasingly asking about alternatives to medical marijuana, primarily in the context of the cost of Rpw therapy (PLN 1,000-4,000/month). CBD 5-9% dried herbs and CBD 10-15% oils are targeted at older adults who are hesitant to undergo a full medical procedure or lack formal indications for Rpw.

THC:CBD ratio comparison

Black-market recreational marijuana today typically has 15-251 TP3 T THC and less than 0.51 TP3 T CBD. This profile maximizes the psychoactive effect but also maximizes the risk of anxiety and psychosis. This is the result of decades of genetic selection for "potency," not safety.

Medical marijuana offers various profiles: THC-dominant (for neuropathic pain), balanced (1:1 THC:CBD for MS spasticity), CBD-dominant (for epilepsy, anxiety), and pure CBD (for specific indications). The choice of profile depends on the indication and patient tolerance. The physician selects the strain based on clinical needs.

The most common myths about marijuana

Many myths have arisen around marijuana, both from supporters and opponents. According to a 2023 CBOS study, 58% Poles have at least one incorrect belief about the effects of medical marijuana (CBOS, 2023). Let's sort through the most important facts and separate them from marketing and propaganda.

Myth 1: "Marijuana is completely harmless"„

False. Marijuana, like any psychoactive substance, has its risks. Addiction affects regular users. Regular use of high-potency strains increases the risk of psychosis, especially in young people. It affects short-term memory and concentration. This substance should be used responsibly, not underestimated.

Myth 2: "Medical marijuana is just legalized recreation"„

False. Medical marijuana is a treatment with specific clinical indications, monitored by a physician. Patients receive a prescription after exhausting standard treatment methods. Sativex, Epidiolex, and dronabinol are registered medications with clinical data comparable to other pharmaceuticals. This is not a "smokescreen" for recreational use.

Myth 3: "CBD works the same as THC, only weaker"„

False. CBD acts on completely different receptors than THC. It doesn't induce psychoactivity, alter perception, or cause a "high." These are two different cannabinoids with different pharmacological profiles. CBD is safe in doses up to 1,500 mg per day according to the WHO, while THC has a narrower therapeutic window.

Myth 4: "Marijuana cures cancer"„

False, in this form. Cannabinoids demonstrate anticancer activity in in vitro studies and animal models, but there is no clinical evidence that they cure cancer in humans. They are used as an adjuvant: they alleviate chemotherapy nausea, support appetite, and reduce pain. This is a treatment support, not a replacement for standard oncology treatments.

Myth 5: "CBD herb will show up on a drug test"„

Partially true. CBD hemp products contain traces of THC (up to 0.31 TP3T). Regular use of large amounts (several grams per day) could theoretically lead to a detectable THC accumulation. In practice, the risk for the typical user is low. However, people in professions requiring regular testing (drivers, co-drivers) should avoid products with any THC content.

Myth 6: "Vaping is as harmful as smoking"„

False. Vaping doesn't involve combustion, so it doesn't produce benzopyrene or carbon monoxide. Studies from 2020-2023 show significantly lower levels of harmful products from vaping than from smoking. This doesn't mean it's completely healthy, but the risk profile is significantly better than traditional smoking.

Frequently asked questions

What is the difference between recreational and medicinal marijuana?

Medicinal marijuana is a standardized pharmaceutical herb with known concentrations of THC and CBD, available in pharmacies only with a prescription. Recreational marijuana comes from uncontrolled sources and remains illegal in Poland. According to patient.gov.pl, the number of medical patients with prescriptions exceeded 300,000 in 2024 (patient.gov.pl, 2024).

Is marijuana legal in Poland in 2026?

Recreational marijuana is illegal in Poland. Medicinal marijuana (dried hemp) has been legal since 2017 with a prescription issued by a licensed physician. CBD products with a THC content below 0.31 TP3T are available over the counter (Journal of Laws 2005 No. 179 item 1485).

How does THC affect the brain and endocannabinoid system?

THC binds to the CB1 receptor in the central nervous system, primarily in the hippocampus, cerebral cortex, and striatum. CB1 activation affects memory, mood, appetite, and time perception. Doses above 10 mg may cause psychotic symptoms in susceptible individuals (Lancet of Psychiatry, 2019).

What are the side effects of medicinal marijuana?

The most common side effects are dry mouth, drowsiness, dizziness, increased appetite, and tachycardia. According to a 2021 BMJ review, 30-40% patients report mild side effects at therapeutic doses. Physical dependence occurs in 9% regular users (NIDA, 2020).

How to get an Rpw prescription for medical marijuana in Poland?

A prescription for Rpw is issued by a licensed physician after diagnosing the following indications: chronic pain, spasticity in MS, nausea during chemotherapy, or resistant epilepsy. The prescription is valid for 30 days and can be filled at a pharmacy licensed to sell narcotics. The patient covers the full cost, PLN 35-65 per gram of dried herb (patient.gov.pl, 2024).

What is the difference between CBD 0.3% THC and medical marijuana?

CBD from hemp contains a maximum of 0.31 TP3 THC, available over-the-counter as cosmetics or supplements. Medical marijuana typically contains 5-221 TP3 THC and 0.5-151 TP3 T CBD, available only with a prescription. The therapeutic effect varies dramatically due to the psychoactivity of THC.

Is marijuana addictive?

Yes, to a limited extent. The risk of addiction for regular users is 9% in the general population and 17% in those starting in their teens (NIDA, 2020). Withdrawal syndrome includes irritability, insomnia, and decreased appetite and persists for 1-2 weeks after discontinuation.

What are the methods of consuming medicinal marijuana?

The most popular methods are vaporization of dried herb (temperature 180-210 degrees C, action in 5-15 minutes), sublingual oils (action 30-90 minutes), edible products (60-180 minutes) and inhalation. Vaporization has the highest bioavailability, 30-35%, compared to 6-20% for oral forms (Frontiers in Pharmacology, 2020).

Summary: What to Remember About Marijuana

Marijuana is a plant with a history of medicinal and recreational use spanning over 5,000 years. It contains over 100 cannabinoids, the most important of which are the psychoactive THC and the non-psychoactive CBD. Both act through the human endocannabinoid system, regulating sleep, appetite, pain, mood, and immunity. This plant isn't a "miracle," but it does have real clinical applications.

Recreational marijuana remains illegal in Poland. Medicinal marijuana has been available on prescription since 2017, and hemp-derived CBD (THC below 0.31 TP3T) is fully legal over-the-counter. These are three distinct legal and qualitative categories that are worth clearly distinguishing when discussing cannabis.

For those interested in therapeutic support, medical marijuana is an option after consulting a doctor. An alternative is hemp-derived CBD products, available over-the-counter, which are usually less expensive and have a lower risk profile. The decision depends on the indication, access to a primary care physician, and the patient's budget.

Maintain a healthy skepticism toward promises of a "miracle drug" and toward demonization. Marijuana is a biologically active substance that requires respect and informed use. Consulting a doctor, reliable sources of information, and quality-controlled products are the foundation of a safe and effective experience.

This article is for informational and educational purposes only and does not constitute medical advice. Consult your doctor before using medicinal marijuana, CBD, or other cannabinoids for therapeutic purposes, especially if you are taking other medications, pregnant, or breastfeeding. Recreational marijuana is illegal in Poland, and possession is subject to criminal penalties.

Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 23, 2026
Last update: April 23, 2026